tiprankstipranks
Trending News
More News >
Inozyme Pharma’s Strategic Acquisition by Biomarin: Analyst Holds Rating Amid Favorable Shareholder Outcome and Strategic Alignment
PremiumRatingsInozyme Pharma’s Strategic Acquisition by Biomarin: Analyst Holds Rating Amid Favorable Shareholder Outcome and Strategic Alignment
2M ago
Inozyme downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Inozyme downgraded to Neutral from Overweight at Piper Sandler
2M ago
Inozyme downgraded to Hold from Buy at Jefferies
Premium
The Fly
Inozyme downgraded to Hold from Buy at Jefferies
2M ago
Inozyme Pharma’s INZ-701 Shows Promising Results in ENERGY-3 Study, Highlighting Investment Potential
PremiumRatingsInozyme Pharma’s INZ-701 Shows Promising Results in ENERGY-3 Study, Highlighting Investment Potential
2M ago
BioMarin says Inozyme deal to strengthen enzyme therapies portfolio
Premium
The Fly
BioMarin says Inozyme deal to strengthen enzyme therapies portfolio
2M ago
Inozyme downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Inozyme downgraded to Neutral from Outperform at Wedbush
2M ago
Inozyme reports Q1 EPS (44c) vs (38c) last year
PremiumThe FlyInozyme reports Q1 EPS (44c) vs (38c) last year
2M ago
Inozyme expects cash to fund operations into Q1 of 2026
Premium
The Fly
Inozyme expects cash to fund operations into Q1 of 2026
2M ago
INZY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INZY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100